Y-mAbs Therapeutics (Priority Review Voucher) is Buildings and Property in United States that focus on Disease Priority Review Voucher business. They cover business area such as Rare Pediatric Disease Priority Review Voucher, (PRV, an NDA, priority review, an expedite eight-month review.
-
Disease Priority Review Voucher
-
230 Park Avenue
Suite 3350
New York, NY
United States
Private
Rare Pediatric Disease Priority Review Voucher(PRVan NDApriority reviewan expedite eight-month review
* We use standard office opening hours in near Y-mAbs Therapeutics (Priority Review Voucher)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Y-mAbs Therapeutics (Priority Review Voucher) is Buildings and Property business from United States that founded in - ( years old in ), Y-mAbs Therapeutics (Priority Review Voucher) business is focusing on Disease Priority Review Voucher.
Y-mAbs Therapeutics (Priority Review Voucher) headquarter office and corporate office address is located in 230 Park Avenue Suite 3350 New York, NY United States.
Y-mAbs Therapeutics (Priority Review Voucher) was founded in United States.
In , Y-mAbs Therapeutics (Priority Review Voucher) is currently focus on Disease Priority Review Voucher sector.
Above is snippet of Google Trends for "Disease Priority Review Voucher" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Y-mAbs Therapeutics (Priority Review Voucher), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
